Board of Directors
The Institute’s Board of Directors is responsible for strategic planning, oversight, and executive management.
Board of directors
Geoffrey A. Simon (Board Chair)
-Managing Director and Senior Vice President, Investments, Simon & Associates Wealth Management
Daniel R. Getts, M.B.A., Ph.D.
– CEO and Co-Founder, Myeloid Therapeutics
Landon S. King, M.D.
– The Johns Hopkins University School of Medicine
Steven S. Sharfstein, M.D.
– Former President and CEO of Sheppard Pratt Health System
Robert F. Muse, Esq.
-Partner, Cunningham Levy Muse LLP
Ken Sonnenfeld, Ph.D.
-Intellectual Property Partner, Ballard Spahr
Heidi Wagner, J.D.
-Senior Vice President and Global Head of Government Affairs, ElevateBio
Mary Rubin
-Founder
Tamar Maltz
-Founder
Milton Maltz
-Founder
Daniel R. Weinberger, M.D.
– Director and Chief Executive Officer of the Lieber Institute for Brain Development